3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
2
Terminated
1
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
300
Carcinoma, Non-Small-Cell Lung
246
Prostatic Neoplasms
195
Neoplasms
193
Lung Neoplasms
151
Multiple Myeloma
145
Neoplasm Metastasis
110
Colorectal Neoplasms
104
Melanoma
97
Ovarian Neoplasms
90
Leukemia, Myeloid, Acute
85
Pancreatic Neoplasms
75
Lymphoma
75
Leukemia, Lymphocytic, Chronic, B-Cell
74
Brain Neoplasms
71
Carcinoma, Renal Cell
67
Carcinoma, Hepatocellular
62
Squamous Cell Carcinoma of Head and Neck
61
Lymphoma, Non-Hodgkin
60
Hematologic Neoplasms
60
Urinary Bladder Neoplasms
59
Head and Neck Neoplasms
57
Triple Negative Breast Neoplasms
55
Glioblastoma
54
Recurrence
52
Lymphoma, Follicular
51
Endometrial Neoplasms
50
Uterine Cervical Neoplasms
49
Stomach Neoplasms
46
Sarcoma
46
Interventions
Anti-Bacterial Agents
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Duodenal Neoplasms
×
90 days
×
Clear all
NCT03631173
2026-04-28
MINIMUM
Oslo University Hospital
Phase NA
Active not recruiting
201 enrolled